Breast Cancer Research
(ISSN: 1465-542X)
Show only: Full-text on Medscape
2009 - 11 (4)
- Recent advances in systemic therapy for breast cancer: new technologies for a new era.
- Recent advances in systemic therapy. When HER2 is not the target: advances in the treatment of HER2-negative metastatic breast cancer.
- Serum 25-hydroxyvitamin D concentrations and postmenopausal breast cancer risk: a nested case control study in the Cancer Prevention Study-II Nutrition Cohort.
- BRCA1-deficient mammary tumor cells are dependent on EZH2 expression and sensitive to Polycomb Repressive Complex 2-inhibitor 3-deazaneplanocin A.
- Resident macrophages influence stem cell activity in the mammary gland.
- Haploinsufficiency for p190B RhoGAP inhibits MMTV-Neu tumor progression.
- It's all in the details: methods in breast development and cancer.
- Dysregulated expression of Fau and MELK is associated with poor prognosis in breast cancer.
- Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells.
- MicroRNA expression profiling of male breast cancer.
- Is there more to Wnt signalling in breast cancer than stabilisation of beta-catenin?
- Transforming growth factor-beta and mutant p53 conspire to induce metastasis by antagonizing p63: a (ternary) complex affair.
- Recent advances in systemic therapy: Advances in systemic therapy for HER2-positive metastatic breast cancer.
- The cytotoxicity of gamma-secretase inhibitor I to breast cancer cells is mediated by proteasome inhibition, not by gamma-secretase inhibition.
- Breast cancer-associated metastasis is significantly increased in a model of autoimmune arthritis.
- An integration of complementary strategies for gene-expression analysis to reveal novel therapeutic opportunities for breast cancer.
- Construction of an MUC-1 promoter driven, conditionally replicating adenovirus that expresses the sodium iodide symporter for gene therapy of breast cancer.
- A novel role for signal transducer and activator of transcription 5b (STAT5b) in beta1-integrin-mediated human breast cancer cell migration.
- Sex steroid metabolism polymorphisms and mammographic density in pre- and early perimenopausal women.
- Presence of HER4 associates with increased sensitivity to Herceptin in patients with metastatic breast cancer.
- Plasma carotenoids, retinol, and tocopherols and postmenopausal breast cancer risk in the Multiethnic Cohort Study: a nested case-control study.
- Alternative use of multiple exons 1 of aromatase gene in cancerous and normal breast tissues from women over the age of 80 years.
- Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients.
- Increased levels of active c-Src distinguish invasive from in situ lobular lesions.
- Dynamics of different-sized solid-state nanocrystals as tracers for a drug-delivery system in the interstitium of a human tumor xenograft.
